Impact of portal hypertension on short- and long-term outcomes after liver resection for intrahepatic cholangiocarcinoma: A propensity score matching analysis

被引:8
作者
Fu, Jun [1 ,2 ]
Chen, Qinjunjie [3 ]
Yu, Yuyan [4 ]
You, Wuyi [4 ]
Ding, Zongren [1 ,2 ]
Gao, Yuzhen [5 ]
Li, Haitao [1 ]
Zeng, Yongyi [1 ]
机构
[1] Fujian Med Univ, Dept Hepatopancreatobiliary Surg, Mengchao Hepatobiliary Hosp, 312 Xihong Rd, Fuzhou, Peoples R China
[2] Big Data Inst Southeast Hepatobiliary Hlth Inform, Fuzhou, Peoples R China
[3] Naval Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg 4, Shanghai, Peoples R China
[4] Fujian Med Univ, Dept Radiol Imaging, Mengchao Hepatobiliary Hosp, Fuzhou, Peoples R China
[5] Zhejiang Univ, Dept Clin Lab, Sch Med, Sir Run Run Shaw Hosp, Hangzhou, Peoples R China
关键词
hepatectomy; liver cancer; portal hypertension; prognosis; propensity score matching; PARTIAL HEPATIC RESECTION; VENOUS-PRESSURE GRADIENT; HEPATOCELLULAR-CARCINOMA; MANAGEMENT; FAILURE; HEPATECTOMY; CIRRHOSIS; SURGERY; RISK; RECURRENCE;
D O I
10.1002/cam4.4222
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective We explored the impact of clinically significant portal hypertension (CSPH) on short- and long-term outcomes of intrahepatic cholangiocarcinoma (ICC) after liver resection (LR). Methods Data of 352 ICC patients with cirrhosis who underwent LR were extracted from the Primary Liver Cancer Big Data (PLCBD) between 2005 and 2015 and reviewed. A nomogram based on logistic analyses was developed to illustrate the influencing factors of post-hepatectomy liver failure (PHLF). The impact of CSPH on long-term survival was explored through propensity score matching (PSM) analysis, log-rank test, Cox proportional hazards model, and Kaplan-Meier curves. Results A total of 106 patients had CSPH, and 246 patients did not. A nomogram established based on GGT level, CSPH, intraoperative blood loss, and multiple tumors had an area under the receiver operating characteristic curve of 0.721 (95% confidence interval [CI] = 0.630-0.812), which displayed a better PHLF predictive value than the MELD score (0.639, 95% CI = 0.532-0.747) and Child-Pugh score (0.612, 95% CI = 0.506-0.719). Moreover, the patients with CSPH had worse overall survival (OS) rates than the patients without CSPH in the whole cohort (p = 0.011) and PSM cohort (p = 0.017). After PSM, multivariable Cox analyses identified that CSPH was an independent risk factor for OS (hazard ratio = 1.585, 95% CI = 1.107-2.269; p = 0.012). Conclusion CSPH is a significant risk factor for PHLF and OS in ICC patients with cirrhosis after surgery. Selecting the proper patients before operation can effectively avoid PHLF and improve the prognosis of ICC.
引用
收藏
页码:6985 / 6997
页数:13
相关论文
共 49 条
[1]   Posthepatectomy Portal Vein Pressure Predicts Liver Failure and Mortality after Major Liver Resection on Noncirrhotic Liver [J].
Allard, Marc-Antoine ;
Adam, Rene ;
Bucur, Petru-Octav ;
Termos, Salah ;
Cunha, Antonio Sa ;
Bismuth, Henri ;
Castaing, Denis ;
Vibert, Eric .
ANNALS OF SURGERY, 2013, 258 (05) :822-830
[2]   Temporal Trends in Liver-Directed Therapy of Patients With Intrahepatic Cholangiocarcinoma in the United States: A Population-Based Analysis [J].
Amini, Neda ;
Ejaz, Aslam ;
Spolverato, Gaya ;
Kim, Yuhree ;
Herman, Joseph M. ;
Pawlik, Timothy M. .
JOURNAL OF SURGICAL ONCOLOGY, 2014, 110 (02) :163-170
[3]   Portal Hypertension and the Outcome of Surgery for Hepatocellular Carcinoma in Compensated Cirrhosis: A Systematic Review and Meta-analysis [J].
Berzigotti, Annalisa ;
Reig, Maria ;
Abraldes, Juan G. ;
Bosch, Jaime ;
Bruix, Jordi .
HEPATOLOGY, 2015, 61 (02) :526-536
[4]   Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis [J].
Boleslawski, E. ;
Petrovai, G. ;
Truant, S. ;
Dharancy, S. ;
Duhamel, A. ;
Salleron, J. ;
Deltenre, P. ;
Lebuffe, G. ;
Mathurin, P. ;
Pruvot, F. R. .
BRITISH JOURNAL OF SURGERY, 2012, 99 (06) :855-863
[5]   Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma [J].
Bridgewater, John ;
Galle, Peter R. ;
Khan, Shahid A. ;
Llovet, Josep M. ;
Park, Joong-Won ;
Patel, Tushar ;
Pawlik, Timothy M. ;
Gores, Gregory J. .
JOURNAL OF HEPATOLOGY, 2014, 60 (06) :1268-1289
[6]   Management of hepatoceullular carcinoma [J].
Bruix, J ;
Sherman, M .
HEPATOLOGY, 2005, 42 (05) :1208-1236
[7]   Clinical management of hepatocellular carcinoma.: Conclusions of the Barcelona-2000 EASL Conference [J].
Bruix, J ;
Sherman, M ;
Llovet, JM ;
Beaugrand, M ;
Lencioni, R ;
Burroughs, AK ;
Christensen, E ;
Pagliaro, L ;
Colombo, M ;
Rodés, J .
JOURNAL OF HEPATOLOGY, 2001, 35 (03) :421-430
[8]   Increasing Incidence of Intrahepatic Cholangiocarcinoma and its Relationship to Chronic Viral Hepatitis [J].
Chang, Kwang-Yu ;
Chang, Jang-Yang ;
Yen, Yun .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2009, 7 (04) :423-427
[9]   Developing a Selection-aided Model to Screen Cirrhotic Intrahepatic Cholangiocarcinoma for Hepatectomy [J].
Chen, Qinjunjie ;
Li, Fengwei ;
Gao, Yuzhen ;
Xue, Hui ;
Li, Zheng ;
Zou, Qifei ;
Xia, Yong ;
Wang, Kui ;
Shen, Feng .
JOURNAL OF CANCER, 2020, 11 (19) :5623-5634
[10]   Surgery for cholangiocarcinoma [J].
Cillo, Umberto ;
Fondevila, Constantino ;
Donadon, Matteo ;
Gringeri, Enrico ;
Mocchegiani, Federico ;
Schlitt, Hans J. ;
Ijzermans, Jan N. M. ;
Vivarelli, Marco ;
Zieniewicz, Krzysztof ;
Damink, Steven W. M. Olde ;
Koerkamp, Bas Groot .
LIVER INTERNATIONAL, 2019, 39 :143-155